Alto Neuroscience, Inc. Operating Lease, Liability, Noncurrent
Alto Neuroscience, Inc. (ANRO) had Operating Lease, Liability, Noncurrent of $3.28 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Noncurrent $3.28M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $3.56M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $3.82M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $3.97M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $3.28M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $3.56M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $3.82M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $3.97M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.21M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $4.41M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.52M 10-K · filed 2026-03-16 |
| 2024-09-30 | $4.62M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |